Laboratory Corporation of America
LH · NYSE
Bulios Fair Price
$270.49
13.3% downside
Current Price
$312.13
According to Bulios Fair Price, LH is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Laboratory Corporation of America Holdings (LH) is an American company providing diagnostic laboratory services to healthcare organizations, physicians, patients, and pharmaceutical companies. Their portfolio includes a wide range of tests in areas such as hematology, clinical chemistry, pathology, genetics, and microbiology, among others. The company is known for its ability to provide fast and accurate test results, which help physicians in diagnosing and treating various diseases. Laboratory Corporation of America Holdings also invests in research and development of new diagnostic methods and technologies to continuously improve its services and offerings. Laboratory Corporation of America Holdings (LH) shares may be attractive to investors seeking investments in companies operating in the diagnostic laboratory services field with an emphasis on quality, reliability, and innovation.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Adam H. Schechter
Employees
71,000
Headquarters
Burlington
Upcoming events
Earnings
Upcoming earnings report